Posted by Michael Wonder on 27 Jan 2023
MSAC publishes agenda for April 2023 PASC meeting
27 January 2023 - The MSAC Secretariat has published a list of applications scheduled to be considered by the PICO Advisory Subcommittee (PASC) on 13 -14 April 2023.
The agenda currently has just 6 items. Applications of note include:
- 1728 – Etranacogene dezaparvovec for the treatment of haemophilia B
- 1740 – N-terminal-pro brain natriuretic peptide (NT-proBNP) to aid in the diagnosis of patients with suspected heart failure in a non-hospital setting
- 1744 – Lutetium Lu 177 octreotate for the treatment of patients with an advanced neuroendocrine and other high somatostatin receptor expressing tumour
